胰腺导管腺癌高危人群MRI标准化筛查方案及报告模板:胰腺癌早期检测联盟专家共识解读OA
Standardized MRI screening protocols and reporting in high-risk individuals of pancreatic ductal adenocarcinoma:interpretation of consensus statement of the pancreatic cancer early detection consortium
胰腺导管腺癌(PDAC)的早期症状隐匿、进展迅速、预后极差.我国《胰腺癌诊疗指南(2022年版)》强调高危人群的早期筛查和精准影像学评估的重要性,并推荐将MRI作为重要的筛查与诊断手段.结合我国PDAC流行病学特征及国内外专家共识要点,本文系统解读国外最新MR筛查方案与报告模板,旨在提高对PDAC的早期检出率,改善病人预后,并为国内指南的持续完善提供循证依据.
Pancreatic ductal adenocarcinoma(PDAC)is characterized by insidious early symptoms,rapid progression,and extremely poor prognosis.The Chinese Guidelines for the Diagnosis and Treatment of Pancreatic Cancer(2022 Edition)emphasize the importance of early screening and precision imaging assessment in high-risk populations,and recommend MRI as an important modality for screening and diagnosis.In conjunction with the epidemiological characteristics of PDAC in China and the key points of domestic and international expert consensus,this article systematically interprets the latest international MRI screening protocols and reporting templates.The aim is to improve the early detection rate of PDAC,improve patient prognosis,and provide evidence-based support for the continuous refinement of domestic guidelines.
汪林;崔磊
南通大学第二附属医院(南通市第一人民医院)影像科,南通 226000南通大学第二附属医院(南通市第一人民医院)影像科,南通 226000
医药卫生
胰腺导管腺癌高危人群磁共振成像标准化报告
Pancreatic ductal adenocarcinomaHigh-risk individualsMagnetic resonance imagingStandardized reporting template
《国际医学放射学杂志》 2026 (1)
6-12,7
2022年南通市基础科学研究和社会民生科技计划项目(指导性)(MSZ2022046)
评论